Published • loading... • Updated
Pinion Immunotherapeutics Publishes Preclinical Data Supporting Clinical-Ready RNA Immunotherapy for HPV-16 Cervical Precancer
The preclinical study found stronger tumor control and T-cell responses with intradermal dosing as Pinion prepares first-in-human testing.
Summary by Rutland Herald
2 Articles
2 Articles
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
